A Rare Case of Subcutaneous Insulin Resistance Presumed to be due to Paraneoplastic Process in Pancreatic Adenocarcinoma

[1]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[2]  S. Gunn,et al.  USE OF INHALED INSULIN IN A PATIENT WITH SUBCUTANEOUS INSULIN RESISTANCE SYNDROME: A RARE CONDITION. , 2019, AACE clinical case reports.

[3]  Suresh T. Chari,et al.  New insights into pancreatic cancer-induced paraneoplastic diabetes , 2013, Nature Reviews Gastroenterology &Hepatology.

[4]  P. Pour,et al.  Diabetes mellitus: a risk factor for pancreatic cancer? , 2005, Langenbeck's Archives of Surgery.

[5]  Lawrence Blonde,et al.  Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial. , 2004, Diabetes care.

[6]  J. Liu,et al.  The intracellular mechanism of insulin resistance in pancreatic cancer patients. , 2000, The Journal of clinical endocrinology and metabolism.

[7]  T. Adrian,et al.  A factor from pancreatic and colonic cancer cells stimulates glucose uptake and lactate production in myoblasts. , 1999, Biochemical and biophysical research communications.

[8]  C. Mantzoros,et al.  Syndromes of Severe Insulin Resistance , 1998 .

[9]  J. Everhart,et al.  Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. , 1995, JAMA.

[10]  L. Gullo,et al.  Diabetes and the risk of pancreatic cancer. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  L. Jorfeldt,et al.  Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer , 1993, The British journal of surgery.

[12]  N. White,et al.  Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin. , 1981, The New England journal of medicine.

[13]  W. Duckworth,et al.  Insulin Resistance Caused by Massive Degradation of Subcutaneous Insulin , 1979, Diabetes.

[14]  J. Levy,et al.  A calculator for HOMA , 2004 .

[15]  T. Adrian,et al.  Pancreatic cancer cells selectively stimulate islet cells to secrete amylin , 1998 .

[16]  X. Ding,et al.  Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin. , 1998, Gastroenterology.

[17]  T. Adrian,et al.  Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? , 1993, American journal of surgery.